Search Within

Rahim Hirani

  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Department of Medicine (9)
  2. Genitourinary Oncology Service (9)
  3. Sloan Kettering Institute Postdocs (9)
  4. Solid Tumor Oncology Division (9)
  5. GSK Faculty (3)
  6. Human Oncology and Pathogenesis Program (3)

More Groups

People
  1. Philip Kantoff (9)
  2. Ying Mazzu (9)
  3. Goutam Chakraborty (8)
  4. Subhiksha Nandakumar (8)
  5. Lina Jehane (7)
  6. Sai Harisha Rajanala (7)

More People

Years
  1. 2022 (2)
  2. 2021 (4)
  3. 2020 (3)
Publications
  1. Cancer Research (3)
  2. Clinical Cancer Research (3)
  3. Journal of Clinical Oncology (2)
  4. Molecular Oncology (1)
Publishers
  1. American Association for Cancer Research (6)
  2. American Society of Clinical Oncology (2)
  3. FEBS Press (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased MYBL2 expression in aggressive hormone-sensitive prostate cancer
    Journal Article

    Yoshikawa, Y.; Stopsack, K. H.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Burton, F.; Chakraborty, G.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; more...
    Molecular Oncology (2022)

    Fulltext@MSK | Save
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bcl-2 inhibitor enhances anti-androgen therapy induced regression of castration sensitive prostate cancer
    Meeting Abstract

    Hirani, R.; Nandakumar, S.; Kalidindi, T.; Fidele, D.; Rajanala, H.; Mazzu, Y.; Yoshikawa, Y.; Jehane, L.; Lee, G. S. M.; de Stanchina, E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Attenuation of SRC kinase activity augments PARP inhibitor-mediated synthetic lethality in BRCA2-altered prostate tumors
    Journal Article

    Chakraborty, G.; Khan Patail, N.; Hirani, R.; Nandakumar, S.; Mazzu, Y. Z.; Yoshikawa, Y.; Atiq, M.; Jehane, L. E.; Stopsack, K. H.; Lee, G. S. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Combined inhibition of androgen signaling and apoptosis pathways in hormone sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Jehane, L. E.; Mazzu, Y. Z.; Yoshikawa, Y.; Rajanala, S. H.; Lee, G. S. M.; Kantoff, P. W.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • The impact of the expression of the transcription factor MYBL2 on outcomes of patients with localized and advanced prostate cancer
    Meeting Abstract

    Yoshikawa, Y.; Wang, X. V.; Chen, Y. H.; Mazzu, Y. Z.; Chakraborty, G.; Jehane, L. E.; Rajanala, S. H.; Hirani, R.; Nandakumar, S.; Stopsack, K. H.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression
    Journal Article

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nandakumar, S.; Stopsack, K. H.; Atiq, M. O.; Komura, K.; Jehane, L.; Hirani, R.; Chadalavada, K.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save